Updated Guidance on Use and Prioritization of Monoclonal Antibody Therapy for Treatment of COVID-19 in Adolescents

Wolf, J., Abzug, M. J., Anosike, B. I., Vora, S. B., Waghmare, A., Sue, P. K., Olivero, R. M., Oliveira, C. R., James, S. H., Morton, T. H., Maron, G. M., Young, J. L., Orscheln, R. C., Schwenk, H. T., Bio, L. L., Willis, Z. I., Lloyd, E. C., Hersh, A. L., Huskins, C. W., … Nakamura, M. M. (2022). Updated Guidance on Use and Prioritization of Monoclonal Antibody Therapy for Treatment of COVID-19 in Adolescents. Journal of the Pediatric Infectious Diseases Society, 11(5), 177–185. https://doi.org/10.1093/jpids/piab124
Authors:
Joshua Wolf
Mark J. Abzug
Brenda I. Anosike
Surabhi B. Vora
Alpana Waghmare
Paul K. Sue
Rosemary M. Olivero
Carlos R. Oliveira
Scott H. James
Theodore H. Morton
Gabriela M. Maron
Jennifer L. Young
Rachel C. Orscheln
Hayden T. Schwenk
Laura L. Bio
Zachary I. Willis
Elizabeth C. Lloyd
Adam L. Hersh
Charles W. Huskins
Vijaya L. Soma
Adam J. Ratner
Molly Hayes
Kevin Downes
Kathleen Chiotos
Steven P. Grapentine
Rachel L. Wattier
Gabriella S. Lamb
Philip Zachariah
Mari M. Nakamura
Affiliated Authors:
Philip Zachariah
Author Keywords:
bamlanivimab and etesevimab
covid-19
pediatric
regen-cov (casirivimab and imdevimab)
sotrovimab
Publication Type:
Article
Unique ID:
10.1093/jpids/piab124
PMID:
Publication Date:
Data Source:
Scopus

Record Created: